Last edition
News about Global Pharma
India-UK FTA to Ease Regulatory Approvals, Boost Indian Pharma Exports: FIEO
Key Indian sectors such as textiles, apparel, leather, gems and jewellery, pharmaceuticals, marine and engineering goods are expected to gain substantially from the proposed India–UK Free Trade Agreement (FTA).
Global Pharma | 23/07/2025 | By Dineshwori | 229
Neuraxpharm Strengthens Global Footprint with Neuraxpharm Australia Launch
Neuraxpharm Group has launched Neuraxpharm Australia as part of its global expansion strategy, bringing key CNS treatments to the Australian market under the leadership of newly appointed Head of Commercial, Avendran Naidu.
Global Pharma | 23/07/2025 | By Mrinmoy Dey | 353
Samsung Biologics has announced its financial results for the second quarter of fiscal year 2025, posting strong growth across both consolidated and standalone metrics.
Global Pharma | 23/07/2025 | By Dineshwori | 1544
Nandani Medical Laboratories has entered into a strategic collaboration with Shanghai-based pharmaceutical machinery innovator Xin Weisheng to advance intelligent pharma quality in India.
Global Pharma | 23/07/2025 | By Dineshwori | 267
Johnson and Johnson to Co-Promote ZILRETTA with Pacira BioSciences
Johnson and Johnson MedTech and Pacira BioSciences have announced a strategic collaboration to expand the market reach of ZILRETTA - Pacira’s extended-release treatment for osteoarthritis knee pain.
Global Pharma | 22/07/2025 | By Dineshwori | 477
Biogen to Invest USD 2 Billion in USA Manufacturing Hub Amid Policy Shifts
The upcoming site will serve as a hub for biologics production, supporting Biogen’s pipeline of therapies for neurological and rare diseases. This strategic move not only enhances the company’s operational resilience but also strengthens its presence in the USA, one of its key markets.
Global Pharma | 22/07/2025 | By Darshana | 152
Cenra Healthcare has announced the expansion of its long-standing partnership with Dr. Reddy’s Laboratories (Taiwan) Ltd. to further improve access to affordable and clinically valuable treatments for patients in Taiwan.
Global Pharma | 22/07/2025 | By Dineshwori | 277
Sanofi to Acquire Vicebio for USD 1.6 Billion
Sanofi has entered into a definitive agreement to acquire Vicebio Ltd., a biopharma company developing next-generation respiratory vaccines, in a deal worth up to USD 1.6 billion, including an upfront payment of USD 1.15 billion.
Global Pharma | 22/07/2025 | By Mrinmoy Dey | 411
AstraZeneca Commits USD 50 Billion to Expand USA Manufacturing and R&D Amid Tariff Pressures
The new Virginia plant will manufacture active pharmaceutical ingredients for AstraZeneca’s upcoming weight-loss and cholesterol drugs, including an oral GLP-1 candidate and a PCSK9 inhibitor. The company said the investment could create tens of thousands of jobs, although exact figures were not disclosed.
Global Pharma | 22/07/2025 | By Darshana | 156
Akums Expands Analgesic Portfolio with New High-Concentration Paracetamol Oral Suspension
Akums Drugs and Pharmaceuticals has introduced Paracetamol Oral Suspension 500mg/5ml in the Indian market, strengthening its position in pain and fever management and adding a significant product to the analgesic and antipyretic category.
Global Pharma | 22/07/2025 | By Dineshwori | 491
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy